USPH Filings — U S Physical Therapy Inc /nv - FilingSpy
USPH
U S Physical Therapy Inc /nv
A national operator of outpatient physical and occupational therapy clinics, running hundreds of locations across dozens of states where patients recover from surgery, sports injuries, and workplace accidents. Founded in 1990 by Texas businessman J. Livingston Kosberg, it grew by partnering with local physical therapists who keep a stake in their own clinics. One quirk: its therapists often retain an ownership interest, so the person treating you may literally be a part-owner of the practice.
U.S. Physical Therapy appoints Nchacha Etta as EVP and CFO effective September 1, 2026
Etta's employment agreement provides an annual base salary of $625,000, an initial equity grant worth approximately $550,000, and a 2026 equity grant of approximately $200,000 plus a prorated discretionary cash bonus in Q1 2027.
Show detailsHide details
Nchacha Etta, former CFO of Omnicell, will become Executive Vice President and Chief Financial Officer of U.S. Physical Therapy, Inc. effective September 1, 2026.
The agreement includes a two-year term with automatic renewals, severance benefits, change-in-control benefits, and non-compete/non-solicitation covenants extending up to two years post-termination.
Jason Curtis, who served as Interim CFO, will continue as Senior Vice President of Finance and Accounting.
The company issued a press release on August 14, 2026, announcing the appointment.
1.01 Entry into a Material Definitive Agreement · 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · 8.01 Other Events · 9.01 Financial Statements and Exhibits
U.S. Physical Therapy updates investor presentation with Q2 2026 financials and growth metrics.
On August 12, 2026, U.S. Physical Therapy, Inc. furnished an updated investor presentation as Exhibit 99.1 under Item 7.01 Regulation FD Disclosure.
Show detailsHide details
The presentation covers company overview, including 796 owned/managed clinics in 45 states, TTM revenues of $812 million, and TTM Adjusted EBITDA of $96 million as of June 30, 2026.
It reports 8% year-over-year revenue growth for the six months ended June 30, 2026, and an annual dividend of $1.84 per share.
The company added 52 owned clinics since August 1, 2025, through de novo openings and acquisitions.
The information is furnished, not filed, and will not be incorporated by reference into SEC filings unless expressly stated.
7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits
U.S. Physical Therapy reports Q1 2026 results, reaffirms full-year guidance
Total revenue was $198 million, up 7.9% year-over-year, with physical therapy revenue up 7.2% and IIP revenue up 11.8%.
Show detailsHide details
Net income attributable to USPH shareholders was $5.0 million in Q1 2026, down from $9.9 million in Q1 2025, partly due to a $2.0 million loss on contingent earn-out revaluation.
The company completed two acquisitions in Q1 2026: a 50% interest in an eight-clinic physical therapy practice and a 70% interest in an industrial injury prevention business.
On April 15, 2026, USPH announced a new 5-year, $450 million credit facility maturing April 14, 2031, upsized from $400 million and replacing a $325 million facility.
Management reaffirmed full-year 2026 adjusted EBITDA guidance of $102 million to $106 million.
The company repurchased non-controlling interests in two partnerships for a total of approximately $14 million during Q1 2026.
7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits